FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "PlanDefinition",
  "id": "IMMZD2DTTBEEncepur",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
      "valueCode": "computable"
    }
  ],
  "url": "http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTTBEEncepur",
  "version": "0.2.0",
  "name": "IMMZD2DTTBEEncepur",
  "title": "IMMZ.D2.DT.TBE.Encepur",
  "type": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
        "code": "eca-rule"
      }
    ]
  },
  "status": "draft",
  "experimental": false,
  "date": "2025-12-05T23:35:21+00:00",
  "publisher": "WHO",
  "contact": [
    {
      "name": "WHO",
      "telecom": [
        {
          "system": "url",
          "value": "http://who.int"
        }
      ]
    }
  ],
  "description": "IMMZ.D2.DT.TBE.Encepur\nEncepur schedule\n(In areas where the disease is highly endemic, implying that there is a high individual risk of infection, WHO recommends that vaccination be offered to all age groups, including children)",
  "relatedArtifact": [
    {
      "type": "citation",
      "citation": "WHO recommendations for routine immunization - summary tables (January 2025)"
    }
  ],
  "library": [
    "http://smart.who.int/immunizations/Library/IMMZD2DTTBEEncepurLogic"
  ],
  "action": [
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "The vaccines manufactured in Austria and Germany (FSME-Immun and Encepur) can be given from > 1 year of age.\nFor the conventional vaccination schedule the dose interval is 1–3 months between doses 1 and 2. For Encepur, the \naccelerated schedule requires vaccination on days 0 and 14, followed by a third dose delivered 9–12 months later. \nIn addition, Encepur may be used on a rapid schedule, with vaccination on days 0, 7 and 21, followed by a fourth dose delivered 12–18 months later.\nFor the conventional vaccination schedule, the dose interval is 1–3 months between doses 1 and 2.\nFor Encepur, the requirement is 9–12 months between doses 2 and 3."
        }
      ],
      "title": "Determine if the client is due for TBE.",
      "description": "Determine if the client is due for TBE vaccine according to the national immunization protocol.\nEncepur schedule (In areas where the disease is highly endemic, implying that there is a high \nindividual risk of infection, WHO recommends that vaccination be offered to all age groups, including children)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Client is due for TBE vaccination",
            "language": "text/cql-identifier",
            "expression": "Client is due for TBE vaccination"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        },
        {
          "path": "medication",
          "expression": {
            "language": "text/cql-expression",
            "expression": "Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE20', display: 'TBE vaccines' } }, display: 'TBE vaccines' }"
          }
        }
      ]
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale",
          "valueMarkdown": "Vaccination against the disease requires a primary series of 3 doses; those who will continue to be at risk \nshould probably have ≥1 booster doses. For both vaccines (FSME-Immun and Encepur) the manufacturers recommend a booster \ndose to be administered 3 years after completion of the primary series. \nVaccination against the disease requires a primary series of 3 doses; those who will continue to be at risk should \nprobably have ≥1 booster doses. Although there is a strong indication that the spacing of boosters could be expanded \nconsiderably from the intervals currently recommended by the manufacturers (every 3–5 years), the evidence is still\ninsufficient for a definitive recommendation on the optimal frequency and number of booster doses."
        }
      ],
      "title": "Determine if the client is due for TBE.",
      "description": "Determine if the client is due for TBE vaccine according to the national immunization protocol.\nEncepur schedule (In areas where the disease is highly endemic, implying that there is a high \nindividual risk of infection, WHO recommends that vaccination be offered to all age groups, including children)",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "The primary series is complete",
            "language": "text/cql-identifier",
            "expression": "The primary series is complete"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTMR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'draft'"
          }
        },
        {
          "path": "intent",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'proposal'"
          }
        },
        {
          "path": "medication",
          "expression": {
            "language": "text/cql-expression",
            "expression": "Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE20', display: 'TBE vaccines' } }, display: 'TBE vaccines' }"
          }
        }
      ]
    },
    {
      "title": "Check for Guidance for the patient regarding IMMZ.D2.DT.TBE.Encepur.",
      "description": "Show Guidance for the patient regarding IMMZ.D2.DT.TBE.Encepur.",
      "condition": [
        {
          "kind": "applicability",
          "expression": {
            "description": "Has Guidance",
            "language": "text/cql-identifier",
            "expression": "Has Guidance"
          }
        }
      ],
      "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTCR",
      "dynamicValue": [
        {
          "path": "status",
          "expression": {
            "language": "text/cql-expression",
            "expression": "'active'"
          }
        },
        {
          "path": "payload.contentString",
          "expression": {
            "language": "text/cql-identifier",
            "expression": "Guidance"
          }
        },
        {
          "path": "category.coding",
          "expression": {
            "description": "Category of communication",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' }"
          }
        },
        {
          "path": "priority",
          "expression": {
            "description": "Alert priority",
            "language": "text/cql-expression",
            "expression": "Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' }"
          }
        }
      ]
    }
  ]
}